Divi’s Laboratories has patented a process for preparing Brivaracetam, a pharmaceutical compound, with high chiral purity. The method involves enzymatic conversion, amidation, ester hydrolysis, Hofmann rearrangement, and N-alkylation. The final product is obtained through esterification and enzymatic resolution. GlobalData’s report on Divi’s Laboratories gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Divi's Laboratories Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Divi's Laboratories, was a key innovation area identified from patents. Divi's Laboratories's grant share as of February 2024 was 68%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11884623B2) discloses a process for the preparation of brivaracetam, a compound with the chemical structure (25)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl] butanamide. The process outlined in the patent involves specific steps for the synthesis of brivaracetam, which is known for its potential therapeutic applications.

The patent claims describe a method for the preparation of brivaracetam, highlighting the importance of the compound's structure and its potential pharmacological properties. The process outlined in the patent provides a detailed procedure for the synthesis of brivaracetam, emphasizing the specific chemical reactions and conditions required for the production of the compound. This patent is significant as it offers a novel approach to the preparation of brivaracetam, which could have implications for the development of new pharmaceutical products or treatments in the future.

To know more about GlobalData’s detailed insights on Divi's Laboratories, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies